A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Histocompatibility Laboratory (HLA) Bookmark and Share

Histocompatibility Laboratory

The Histocompatibility Laboratory at City of Hope provides the highest standard of human leukocyte antigen typing services on a contract basis, as well as for City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation. In operation since 1975, our clientele includes a number of prominent institutions such as Kaiser Permanente of Southern California, Loyola University in Chicago, BloodSource and the University of California at Davis, among others. The Histocompatibility Laboratory is staffed by specially trained technologists and utilizes state-of-the-art technology in the field of histocompatibility.
 
High Quality Service and Rapid Response
City of Hope’s Histocompatibility Laboratory maintains high quality service and rapid response times. With the exception of unique circumstances, we communicate HLA typing results within a maximum of ten (10) working days upon receipt of a blood specimen. Results of histocompatibility testing can be reported by phone, fax or email as soon as they are available, and will be followed by an official written report.
 
Licenses and Accreditations
City of Hope’s Histocompatibility Laboratory is fully accredited by The American Society of Histocompatibility and Immunogenetics (ASHI), College of American Pathologists (CAP), and Clinical Laboratory Improvement Amendments (CLIA 88).
 
The laboratory holds the following licenses:
  • CLIA #05D0665695
  • CA State License #209978

HLA and Stem Cell Transplantation

This page explains the field of “HLA,” its role in stem cell transplantation and some relevant terminology. It also addresses the blood tests your doctor will order before a stem cell transplant, and the useful information the blood sample provides.
 
Stem Cell Transplants
In order to treat certain diseases, it is necessary to give whole body irradiation and high dose chemotherapy. While this therapy destroys malignant cells, unfortunately it also destroys the cells responsible for generating red blood cells, white blood cells and platelets. In order for the patient to survive after radiation and chemotherapy, these cells (called “hematopoietic stem cells”) must be transfused back into the patient. They then migrate to the bone marrow, divide, and eventually produce new blood cells and platelets.

There are three main sources of hematopoietic stem cells. Stem cells that circulate throughout the blood stream are called “peripheral blood stem cells” or PBSCs. Another source is the bone marrow, where most stem cells reside. A third source of stem cells is the umbilical cord of a newborn baby.

If the hematopoietic stem cells transfused into the patient are from another individual, it is best if the cells carry the same HLA molecules as the patient – otherwise, the patient may either reject the stem cell transplant or the transplanted stem cells may react to the patient’s tissues in what is termed “graft versus host disease.”
 
What is HLA?
HLA stands for “Human Leukocyte Antigen.” These are protein molecules that we inherit from our parents. We currently know about nearly 600 different HLA molecules. Before you have a stem cell transplant, your HLA type must be determined. This is done by taking a blood sample.

The laboratory will also determine the HLA type of anyone who may donate stem cells to you. It is important in stem cell transplants to see how closely the HLA of the transplant patient matches the HLA of the stem cell donor. The HLA “match” is the number of HLA molecules that any two people have in common. HLA matching is usually based on six HLA molecules. The more molecules two people share, the better the match. When two individuals share the same HLA type, they are said to be a good match. That is, their immune systems will not see each other as “foreign” and are less likely to attack each other.

The most likely place to find an HLA match between two people is among siblings (brothers and sisters who have the same mother and same father). If two siblings inherit the very same HLA molecules from both parents, they are said to be an “HLA identical match.”

You have a 25 percent (1 in 4) chance of being an HLA identical match with your sibling. Why? Because there is a basic rule in HLA inheritance: you have a 25 percent chance of inheriting the same HLA molecules as your sibling, a 25 percent chance of inheriting none of the same HLA molecules as your sibling, and a 50 percent chance of inheriting half of the same HLA molecules as your sibling.

However, two unrelated people can just happen to be a good HLA match, too. Although it is less likely, it is possible that you could have some of the same HLA molecules as a friend or as someone you don’t even know. If you and your friend share three HLA molecules, for example, then you are said to be a “three HLA antigen match.”

Finding the Best Match
When a doctor decides that a stem cell transplant is the best treatment for a patient, he or she will request a family study. The patient, all of his or her siblings, and usually their parents will have their blood drawn for HLA typing. If one of the family members is an HLA identical match, the lab will do further testing to be absolutely sure that they are the best match possible. This usually involves taking the patient’s and the donor’s DNA from the blood cells and typing the HLA genes to show that they are identical.

If none of the siblings or the parents are a good HLA match, the doctor will sometimes ask to have additional family members tested. These are usually aunts, uncles, cousins and grandparents. If it happens that there are no close HLA matches within the patient’s family,a search will be initiated for an unrelated donor with the same HLA molecules as the patient.
 
Glossary of HLA Terms
  • HLA: human leukocyte antigen, proteins we inherit from our parents
  • HLA Matching: the number of HLA molecules two people have in common
  • HLA Antibodies: proteins in the patient's blood against the donor's HLA that could attack transplanted or transfused cells
  • PRA: panel reactive antibody, a measure of how much HLA antibody the patient has
  • Stem Cell: cells responsible for generating red blood cells, white blood cells, and platelets
  • Red Blood Cell: the cells that carry oxygen to all parts of the body
  • White Blood Cell: the cells of the immune system that fight off germs
  • Platelets: the cells that form clots to stop bleeding
  • Bone Marrow: the inner spongy portion of large bones, where most stem cells reside
  • Graft versus Host Disease: an immune attack by transplanted donor cells against the patient’s body
  • ABO: blood type, a person can be A, B, AB or O blood type

Available Tests

In addition to standard typing as itemized in the chart below, City of Hope's Histocompatiblity Laboratory now offers:

Tests                                                          Methodology
 
HLA-AB Typing                                                               Luminex
 
Donor/Recipient Crossmatch                                    Serology
 
HLA Antibody Screening                                              Serology/SSOP
 
B27 Typing                                                                      PCR-SSP/SBT
 
HLA-ABC Low Resolution Typing                               SSOP
 
HLA-DRB1, DQB1 Low Resolution Typing               SSOP
 
HLA-ABC High Resolution Typing                              PCR-SSP or SBT
 
HLA-DRB1, DPB1, DQB1 High ResolutionTyping  PCR-SSP or SBT

Engraftment Analysis                                                   Short Tandem Repeat
 
 
 
Fees for tests will be provided upon request.
 

Specimen Requirements

Please adhere to these instructions for sampling and labeling.
 
Requisition Form
  • Download the requisition form here in Adobe Acrobat (.pdf) format. If you don't have Adobe Acrobat Reader, you can download it for free here.
  • Specimens should be sent with a completed requisition form for overnight delivery using proper handling techniques.
  • Include completed HLA Laboratory requisition form with shipment.
  • Call the laboratory at (877) 443-GENE (4363) upon shipping the specimens.
 
Before the Specimen is Drawn
  • Call the laboratory at (877) 443-GENE (4363) to schedule testing.
 
Drawing and Storing Specimen for Shipment
  • 5-10 cc of blood should be drawn and immediately transferred into 2 yellow tope tubes (ACD Solution A) and one red top tube.
  • Mix well by inverting tubes several times.
  • Store specimen at room temperature.
  • Include completed HLA Laboratory requisition form with shipment.
     
Labeling Specimen
  • Please label each sample with the following information:
  • Date blood was drawn
  • Name, birthday, race and patient’s I.D. number
  • Recipient/donor relationship
 
 

Contact Us

For more information or to request a test, please contact us via:

Phone: 877-443-GENE (4363)
Fax: 626-301-8888
Email: dsenitzer@coh.org

City of Hope
Attention: Histocompatibility Laboratory
1500 E. Duarte Road
Duarte, CA 91010

Directions and Maps

Histocompatibility Laboratory (HLA)

Histocompatibility Laboratory

The Histocompatibility Laboratory at City of Hope provides the highest standard of human leukocyte antigen typing services on a contract basis, as well as for City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation. In operation since 1975, our clientele includes a number of prominent institutions such as Kaiser Permanente of Southern California, Loyola University in Chicago, BloodSource and the University of California at Davis, among others. The Histocompatibility Laboratory is staffed by specially trained technologists and utilizes state-of-the-art technology in the field of histocompatibility.
 
High Quality Service and Rapid Response
City of Hope’s Histocompatibility Laboratory maintains high quality service and rapid response times. With the exception of unique circumstances, we communicate HLA typing results within a maximum of ten (10) working days upon receipt of a blood specimen. Results of histocompatibility testing can be reported by phone, fax or email as soon as they are available, and will be followed by an official written report.
 
Licenses and Accreditations
City of Hope’s Histocompatibility Laboratory is fully accredited by The American Society of Histocompatibility and Immunogenetics (ASHI), College of American Pathologists (CAP), and Clinical Laboratory Improvement Amendments (CLIA 88).
 
The laboratory holds the following licenses:
  • CLIA #05D0665695
  • CA State License #209978

HLA and Stem Cell Transplantation

HLA and Stem Cell Transplantation

This page explains the field of “HLA,” its role in stem cell transplantation and some relevant terminology. It also addresses the blood tests your doctor will order before a stem cell transplant, and the useful information the blood sample provides.
 
Stem Cell Transplants
In order to treat certain diseases, it is necessary to give whole body irradiation and high dose chemotherapy. While this therapy destroys malignant cells, unfortunately it also destroys the cells responsible for generating red blood cells, white blood cells and platelets. In order for the patient to survive after radiation and chemotherapy, these cells (called “hematopoietic stem cells”) must be transfused back into the patient. They then migrate to the bone marrow, divide, and eventually produce new blood cells and platelets.

There are three main sources of hematopoietic stem cells. Stem cells that circulate throughout the blood stream are called “peripheral blood stem cells” or PBSCs. Another source is the bone marrow, where most stem cells reside. A third source of stem cells is the umbilical cord of a newborn baby.

If the hematopoietic stem cells transfused into the patient are from another individual, it is best if the cells carry the same HLA molecules as the patient – otherwise, the patient may either reject the stem cell transplant or the transplanted stem cells may react to the patient’s tissues in what is termed “graft versus host disease.”
 
What is HLA?
HLA stands for “Human Leukocyte Antigen.” These are protein molecules that we inherit from our parents. We currently know about nearly 600 different HLA molecules. Before you have a stem cell transplant, your HLA type must be determined. This is done by taking a blood sample.

The laboratory will also determine the HLA type of anyone who may donate stem cells to you. It is important in stem cell transplants to see how closely the HLA of the transplant patient matches the HLA of the stem cell donor. The HLA “match” is the number of HLA molecules that any two people have in common. HLA matching is usually based on six HLA molecules. The more molecules two people share, the better the match. When two individuals share the same HLA type, they are said to be a good match. That is, their immune systems will not see each other as “foreign” and are less likely to attack each other.

The most likely place to find an HLA match between two people is among siblings (brothers and sisters who have the same mother and same father). If two siblings inherit the very same HLA molecules from both parents, they are said to be an “HLA identical match.”

You have a 25 percent (1 in 4) chance of being an HLA identical match with your sibling. Why? Because there is a basic rule in HLA inheritance: you have a 25 percent chance of inheriting the same HLA molecules as your sibling, a 25 percent chance of inheriting none of the same HLA molecules as your sibling, and a 50 percent chance of inheriting half of the same HLA molecules as your sibling.

However, two unrelated people can just happen to be a good HLA match, too. Although it is less likely, it is possible that you could have some of the same HLA molecules as a friend or as someone you don’t even know. If you and your friend share three HLA molecules, for example, then you are said to be a “three HLA antigen match.”

Finding the Best Match
When a doctor decides that a stem cell transplant is the best treatment for a patient, he or she will request a family study. The patient, all of his or her siblings, and usually their parents will have their blood drawn for HLA typing. If one of the family members is an HLA identical match, the lab will do further testing to be absolutely sure that they are the best match possible. This usually involves taking the patient’s and the donor’s DNA from the blood cells and typing the HLA genes to show that they are identical.

If none of the siblings or the parents are a good HLA match, the doctor will sometimes ask to have additional family members tested. These are usually aunts, uncles, cousins and grandparents. If it happens that there are no close HLA matches within the patient’s family,a search will be initiated for an unrelated donor with the same HLA molecules as the patient.
 
Glossary of HLA Terms
  • HLA: human leukocyte antigen, proteins we inherit from our parents
  • HLA Matching: the number of HLA molecules two people have in common
  • HLA Antibodies: proteins in the patient's blood against the donor's HLA that could attack transplanted or transfused cells
  • PRA: panel reactive antibody, a measure of how much HLA antibody the patient has
  • Stem Cell: cells responsible for generating red blood cells, white blood cells, and platelets
  • Red Blood Cell: the cells that carry oxygen to all parts of the body
  • White Blood Cell: the cells of the immune system that fight off germs
  • Platelets: the cells that form clots to stop bleeding
  • Bone Marrow: the inner spongy portion of large bones, where most stem cells reside
  • Graft versus Host Disease: an immune attack by transplanted donor cells against the patient’s body
  • ABO: blood type, a person can be A, B, AB or O blood type

Available Tests

Available Tests

In addition to standard typing as itemized in the chart below, City of Hope's Histocompatiblity Laboratory now offers:

Tests                                                          Methodology
 
HLA-AB Typing                                                               Luminex
 
Donor/Recipient Crossmatch                                    Serology
 
HLA Antibody Screening                                              Serology/SSOP
 
B27 Typing                                                                      PCR-SSP/SBT
 
HLA-ABC Low Resolution Typing                               SSOP
 
HLA-DRB1, DQB1 Low Resolution Typing               SSOP
 
HLA-ABC High Resolution Typing                              PCR-SSP or SBT
 
HLA-DRB1, DPB1, DQB1 High ResolutionTyping  PCR-SSP or SBT

Engraftment Analysis                                                   Short Tandem Repeat
 
 
 
Fees for tests will be provided upon request.
 

Specimen Requirements

Specimen Requirements

Please adhere to these instructions for sampling and labeling.
 
Requisition Form
  • Download the requisition form here in Adobe Acrobat (.pdf) format. If you don't have Adobe Acrobat Reader, you can download it for free here.
  • Specimens should be sent with a completed requisition form for overnight delivery using proper handling techniques.
  • Include completed HLA Laboratory requisition form with shipment.
  • Call the laboratory at (877) 443-GENE (4363) upon shipping the specimens.
 
Before the Specimen is Drawn
  • Call the laboratory at (877) 443-GENE (4363) to schedule testing.
 
Drawing and Storing Specimen for Shipment
  • 5-10 cc of blood should be drawn and immediately transferred into 2 yellow tope tubes (ACD Solution A) and one red top tube.
  • Mix well by inverting tubes several times.
  • Store specimen at room temperature.
  • Include completed HLA Laboratory requisition form with shipment.
     
Labeling Specimen
  • Please label each sample with the following information:
  • Date blood was drawn
  • Name, birthday, race and patient’s I.D. number
  • Recipient/donor relationship
 
 

Contact Us

Contact Us

For more information or to request a test, please contact us via:

Phone: 877-443-GENE (4363)
Fax: 626-301-8888
Email: dsenitzer@coh.org

City of Hope
Attention: Histocompatibility Laboratory
1500 E. Duarte Road
Duarte, CA 91010

Directions and Maps

Patient Care Overview

City of Hope Locations

Faces of Cancer

Meet City of Hope patients and their families.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Cancer Expertise Matters


NEWS & UPDATES
  • Brain cancer may be one of the most-frightening diagnoses people can receive, striking at the very center of who we are as individuals. Further, it often develops over time, causing no symptoms until it’s already advanced. Listen to City of Hope Radio as Behnam Badie, M.D., director of the Brain Tumor Pro...
  • The whole is greater than the sum of its parts. It takes a village. No man is an island. Choose your aphorism: It’s a simple truth that collaboration usually is better than isolation. That’s especially true when you’re trying to introduce healthful habits and deliver health care to people at risk of disease and...
  • When Maryland Governor Larry Hogan announced earlier this week that he has the most common form of non-Hodgkin lymphoma, he was giving voice to the experience of more than 71,000 Americans each year. The announcement came with Hogan’s promise to stay in office while undergoing aggressive treatment for the...
  • The spine can be affected by many different kinds of tumors. Malignant, or cancerous, tumors can arise within the spine itself. Secondary spinal tumors, which are actually much more common, begin as cancers in another part of the body, such as the breast and prostate, and then spread, or metastasize, to the spi...
  • Although most cancer occurs in older adults, the bulk of cancer research doesn’t focus on this vulnerable and fast-growing population. City of Hope and its Cancer and Aging Research Team aim to change that, and they’re getting a significant boost from Professional Practice Leader Peggy Burhenn, R.N....
  • Liz Graef-Larcher’s first brain tumor was discovered by accident six years ago. The then-48-year-old with a long history of sinus problems and headaches had been sent for an MRI, and the scan found a lesion in her brain called a meningioma – a tumor that arises in the meninges, the layers of tissue that cover a...
  • The colon and rectum are parts of the body’s gastrointestinal system, also called the digestive tract. After food is digested in the stomach and nutrients are absorbed in the small intestine, the remaining material moves down into the lower large intestine (colon) where water and nutrients are absorbed. The low...
  • If there is one truism about hospital stays it is that patients want to get out. For many, however, the joy of being discharged is tempered by the unexpected challenges that recovery in a new setting may pose. Even with professional help, the quality of care and treatment that patients receive at City of Hope [...
  • Jana Portnow, M.D., associate director of the Brain Tumor Program at City of Hope, didn’t expect to specialize in treating brain tumors. But, early in her career, she undertook a year of research on pain management and palliative care and, in that program, got to know many patients with brain tumors. After that...
  • Ask any patient: Nurses are as pivotal in their care as doctors. They answer the call of a patient in the middle of the night, they hold the patient’s hand as he or she takes on yet another round of treatment and, in the best-case scenario, they wave goodbye as the patient leaves the hospital, […]
  • Many oncologists, not to mention their patients, might think that there’s no place for mathematical analysis in the treatment of cancer. They might think that all treatment decisions are based on unique factors affecting individual patients, with no connection to other patients and their treatment regimen...
  • Within three days in 2007, Stephanie Hosford, then 37, learned that she was pregnant with her long-awaited second child – and that she had triple-negative breast cancer. Soon afterward, Hosford discovered that she and her husband, Grant, had been approved to adopt a little girl from China.  After encountering m...
  • That’s not an echo you hear, it’s another study linking weight to breast cancer risk. It’s also another reason to improve the health of our overall community. In a report published online June 11 in the journal JAMA Oncology, researchers have concluded that women who are both obese and postmenopausal face...
  • Cancer and other life-threatening illnesses can be overwhelming experiences for adults. For children, who lack the life experience and context to put their diagnosis in perspective, the treatment and follow-up can be especially isolating. City of Hope’s youngest patients recently got a chance to overcome that i...
  • When explaining breast cancer treatment options, breast cancer specialists typically discuss the best therapies currently available, working with their patients to create the most effective treatment regimens. Recently, however, City of Hope specialists – in oncology, surgery and immunology – came together to d...